Trovagene Inc (NASDAQ:TROV)

6.29
Delayed Data
As of Mar 05
 -0.05 / -0.79%
Today’s Change
2.97
Today|||52-Week Range
7.10
+46.28%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close6.34
Today’s open6.30
Day’s range-- - --
Volume155,018
Average volume (3 months)208,256
Market cap$148.7M
Dividend yield--
Data as of 03/05/2015

Growth & Valuation

Earnings growth (last year)+21.35%
Earnings growth (this year)-8.10%
Earnings growth (next 5 years)--
Revenue growth (last year)-42.44%
P/E ratioNM
Price/Sales375.92
Price/Book5.88

Competitors

 Today’s
change
Today’s
% change
ERBERBA Diagnostics Inc-0.03-0.88%
VCYTVeracyte Inc-0.06-0.70%
CGIXCancer Genetics Inc-0.04-0.47%
GALTGalectin Therapeutic...+0.12+3.36%
Data as of 03/05/2015

Financials

Next reporting dateMarch 13, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$259.2K
Annual profit (last year)-$11.8M
Net profit margin-4,555.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account